Lpl Financial LLC Aurinia Pharmaceuticals Inc. Transaction History

Lpl Financial LLC

$238 Billion
Q4 2024

A detailed history of Lpl Financial LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 46,600 shares of AUPH stock, worth $371,402. This represents 0.0% of its overall portfolio holdings.

Number of Shares

46,600

Previous 38,273 21.76%

Holding current value

$371,402

Previous $280,000 49.29%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$6.75 - $10.44 $56,207 - $86,933	8,327 Added 21.76%	46,600 $418,000
Q3 2024 Nov 08, 2024	BUY	$5.32 - $7.33 $11,124 - $15,327	2,091 Added 5.78%	38,273 $280,000
Q2 2024 Aug 07, 2024	BUY	$4.81 - $5.78 $15,271 - $18,351	3,175 Added 9.62%	36,182 $206,000
Q1 2024 May 10, 2024	SELL	$4.93 - $9.31 $1,035 - $1,955	-210 Reduced 0.63%	33,007 $165,000
Q4 2023 Feb 14, 2024	BUY	$7.13 - $9.49 $4,278 - $5,694	600 Added 1.84%	33,217 $298,000
Q3 2023 Nov 13, 2023	BUY	$7.77 - $12.27 $22,533 - $35,583	2,900 Added 9.76%	32,617 $253,000
Q2 2023 Jul 31, 2023	BUY	$8.96 - $11.69 $43,088 - $56,217	4,809 Added 19.31%	29,717 $287,000
Q1 2023 May 10, 2023	SELL	$5.94 - $11.27 $2,560 - $4,857	-431 Reduced 1.7%	24,908 $272,000
Q4 2022 Feb 07, 2023	SELL	$4.11 - $8.14 $3,209 - $6,357	-781 Reduced 2.99%	25,339 $109,000
Q3 2022 Nov 14, 2022	SELL	$6.66 - $12.39 $2,817 - $5,240	-423 Reduced 1.59%	26,120 $196,000
Q2 2022 Aug 12, 2022	SELL	$8.95 - $12.8 $21,480 - $30,720	-2,400 Reduced 8.29%	26,543 $267,000
Q1 2022 May 16, 2022	BUY	$10.05 - $22.48 $30,753 - $68,788	3,060 Added 11.82%	28,943 $358,000
Q4 2021 Feb 14, 2022	BUY	$17.78 - $33.08 $140,977 - $262,291	7,929 Added 44.16%	25,883 $592,000
Q3 2021 Nov 15, 2021	SELL	$10.93 - $23.55 $44,113 - $95,047	-4,036 Reduced 18.35%	17,954 $397,000
Q2 2021 Aug 13, 2021	BUY	$10.0 - $14.52 $78,970 - $114,664	7,897 Added 56.03%	21,990 $285,000
Q1 2021 May 14, 2021	BUY	$12.3 - $18.73 $14,637 - $22,288	1,190 Added 9.22%	14,093 $183,000
Q4 2020 Feb 12, 2021	BUY	$12.94 - $16.05 $166,964 - $207,093	12,903 New	12,903 $178,000

Others Institutions Holding AUPH

# of Institutions

223

Shares Held

59.4M

Call Options Held

1.17M

Put Options Held

1.54M

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.13B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Aurinia Pharmaceuticals Inc. Transaction History